Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04657718

CLAIM: Using the KODEX-EPD System to Guide PaCing Lead Placements, A First In Man Study.

CLAIM: Using the KODEX-EPDTM System to Guide PaCing Lead Placements, A First In Man Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
EPD Solutions, A Philips Company · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, multi-center (2-3 sites), non-randomized, open label, single arm 3 phase study: 1. Phase 1 or Evaluation Phase: Where the KODEX-EPD System will be used to exclusively monitor the entire implantation procedure; the KODEX-EPD system will not be used for guidance during the lead implantation workflow. 2. Phase 2 - KODEX-EPD-assisted Phase: Where the KODEX-EPD system will be used for cardiac imaging acquisition, guidance during lead implantation in conjunction with fluoroscopic imaging 3. Phase 3 - KODEX-EPD-guided Phase: Where the KODEX\_EPD System will be used as the leading imaging modality during the lead implantation workflow. Fluoro can be used; * up until the part of the lead implantation workflow that is the scope of this investigation. * As a bailout, when the operator declares failure to attempt.

Conditions

Interventions

TypeNameDescription
DEVICEKODEX-EPD systemCardiac pacing leads implantation for PM, ICD, CRT, HBP and LBBP

Timeline

Start date
2021-01-01
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2020-12-08
Last updated
2023-02-16

Regulatory

Source: ClinicalTrials.gov record NCT04657718. Inclusion in this directory is not an endorsement.